United States · Business magazines · Axios Markets

Blackstone is becoming a biotech bank

Published by Axios Markets · United States 20 h ago

Detailed summary

Why it matters: Blackstone has become something akin to a biotech bank, helping offset drug development costs for Pfizer, Apogee, Alnylam, Boston Scientific, J&J, Merck, and…

Read the full article on Axios Markets Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.axios.com)

Also worth reading

Entrepreneur

You’re Not Behind on AI Agents Yet. Learn How They Work in 10 Minutes, Before Your Competitors Get Ahead

Fortune

FAA lifts ground stop as homeland security chief blames tech upgrades for ‘overwhelming’ antiquated systems and rules out cyberattack for now

Inc.

This Week, the FAA Rolled Out AI Air Traffic Management. Then It Grounded Flights Nationwide

Fast Company

Apple TV has a new ASL feature, offering a richer language experience beyond captions

Quartz

How boards investigate a CEO: 10 parts of an internal probe

Kiplinger